CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan
收藏  |  浏览/下载:40/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:31/0  |  提交时间:2019/12/05
EBV Promotes Human CD8(+) NKT Cell Development 期刊论文
PLOS PATHOGENS, 2010, 卷号: 6, 期号: 5
作者:  He Yuling;  Xiao Ruijing;  Ji Xiang;  Li Li;  Chen Lang
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
EBV-Induced Human CD8(+) NKT Cells Synergise CD4(+) NKT Cells Suppressing EBV-Associated Tumours upon Induction of Th1-Bias 期刊论文
CELLULAR & MOLECULAR IMMUNOLOGY, 2009, 卷号: 6, 期号: 5
作者:  Xiao, Wei;  Li, Li;  Zhou, Rui;  Xiao, Ruijing;  Wang, Yujuan
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
EBV-Induced Human CD8(+) NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies 期刊论文
CANCER RESEARCH, 2009, 卷号: 69, 期号: 20
作者:  He Yuling;  Xiao Ruijing;  Li Li;  Ji Xiang;  Zhou Rui
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace